All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
Supply Chain and Fair Trade: Lessons Learned from the Pandemic
By Tim Clarot, Industry Consultant At this writing, we are approximately four years past the official declaration of the COVID-19 pandemic. The pandemic served as...
Present Foresight to Protect the Future
By Mark Land, MS, RAC-US, AAHP President AAHP planned this issue of the newsletter to focus on stewardship several months ago as part of our...
How Artificial Intelligence Is Impacting CPG Companies
By Ray Petrick, Vice President of Sales, Boiron USA Interest in AI is growing fast. Companies are experimenting and trying new ways to utilize AI...
Quality/Regulatory Support of New Product Introductions
By Mark Land, MS, RAC-US, AAHP President The introduction of a new product at retail is a team effort. Meeting technical information requirements to support...
FDA Issues FY23 Drug Safety Priorities Report
In February 2024, FDA's Center for Drug Evaluation and Research (CDER) published its ninth yearly report describing key safety programs and activities, and illustrating the...
Meet AAHP’s Newest Board Member
Brenda Van Goethem, Director of Regulatory Compliance & Change Management for Nature's Way, is the newest member of AAHP's Board of Directors. Elections for two-year...
FDA Warnings: Mistakes to Avoid
What Is Your Company Paying Attention To? And what is the FDA paying attention to? In a recent 30-day period, FDA sent 33 warning letters...
